Inventors:
- San Jose CA, US
Michael Viet Thang Vu - San Jose CA, US
Robert Daniel Force - Lathrop CA, US
Alexander Nelson Thacker - San Juan Capistrano CA, US
Aaron Nicholas Adams - Aptos CA, US
International Classification:
A61K 36/185
A61K 31/01
A61K 31/352
A61K 31/047
A61K 31/015
A61K 31/045
Abstract:
A class of medically-effective formulations comprising cannabinoids, and terpenes, using β-myrcene to improve effectiveness. B-myrcene decreases resistance across the blood-brain barrier for both itself and a plurality of other medically-active compounds such as other terpenes, cannabinoids, and flavonoids. Further, β-myrcene has been determined to raise the saturation level of the cannabinoid receptor CB1 for phytocannabinoids such as delta(9)-tetrahydrocannabinol, and to increase cell membrane permeability for itself as well as cannabinoids, terpenes, flavonoids and other naturally occurring cannabis compounds, thereby improving therapeutic benefits of cannbis formulations.